Skip to content
Review Open access

Mapping the methodological framework of diabetic retinopathy interventional trials: a scoping review on trial design, execution, and reporting practices

Oct 2026 · Frontiers in Endocrinology · Vol 17 · 0 citations · 44 references
Medicine

TL;DR

This review represents the first comprehensive assessment of current DR clinical research, exposing key design weaknesses in existing trials and identifying methodological gaps identified that are urgently needed to generate robust evidence that can guide optimal treatment strategies.

Abstract

Background Diabetic Retinopathy (DR) is a prevalent and sight-threatening ocular complication of diabetes, and one of the leading causes of vision loss and blindness among the working-age population worldwide. Driven by a growing understanding of the pathophysiological mechanisms underlying DR, treatment strategies have evolved from a sole focus on glycemic control to comprehensive, multi-targeted, and multimodal therapies. This study systematically summarizes the characteristics of current clinical trials focused on DR treatment and evaluates the employed research methodologies. The aim of this review is to explore methodological trends in specific domains, with the hope that such insights may inform future efforts to optimize trial design and improve trial quality. Methods This study followed the PRISMA-ScR reporting guidelines. Clinical trials registered on ClinicalTrials.gov and the Chinese Clinical Trial Registry (ChiCTR) were retrieved. In addition, clinical trials indexed in PubMed from July 23, 2016 to July 23, 2026 were retrieved. Data from the included studies were extracted and presented in tabular form. Results Clinical research targeting DR has expanded rapidly, reflecting a shift toward diverse interventions like anti-Vascular endothelial growth factor(anti-VEGF) drugs, laser treatments, and combined therapies. However, several methodological limitations were noted in the included studies, including the failure to specify diabetes type in over half of the cases, a predominance of small-sample trials, inconsistent reporting of intervention duration, and limited implementation of blinding due to practical constraints in ophthalmic interventions. Conclusion This review represents the first comprehensive assessment of current DR clinical research, exposing key design weaknesses in existing trials. Future meta-analyses and systematic evaluations, informed by the methodological gaps identified in this review, are urgently needed to generate robust evidence that can guide optimal treatment strategies.

Read PDF

Similar papers

Review Open access Sep 2026

Delivery models of diabetic retinopathy services in low- and middle-income countries: a scoping review

Diabetic retinopathy (DR) is a leading cause of vision loss, and its burden is projected to increase disproportionately in low- and middle-income countries (LMICs). Although blindness from DR is preventable through screening and prompt treatment, most LMICs lack organised DR service delivery models due to resourc...

S. Mdala, P. Kayange, Thokozani Zungu et al. · 0 citations
Review Open access Nov 2026

Impact of different treatment regimens on long-term prognosis in patients with proliferative diabetic retinopathy: a systematic review.

AIM To evaluate the long-term prognostic outcomes associated with different treatment regimens for PDR, including panretinal photocoagulation (PRP), anti-vascular endothelial growth factor (anti-VEGF) therapy, vitrectomy, and combination approaches. METHODS A comprehensive literature search was conducted across PubMe...

Yu-Man Li, Feng Zhao, Wen-Tao Li et al. · 0 citations
Open access Sep 2026

Analysis of clinical characteristics of diabetic retinopathy: A retrospective, single-centre clinical study

ABSTRACT Objective: To investigate the variations in clinical characteristics, metabolic profiles, and visual status across different stages of diabetic retinopathy (DR) to enable early intervention. Methodology: A retrospective analysis of patients with diabetes was conducted at Shijiazhuang People’s Hospital from Jan...

Li Li, Yu-Hua Hao · 0 citations
Review Sep 2026

Effect of systemic fibrates on diabetic retinopathy prevention and progression: A comprehensive systematic review and meta-analysis.

Diabetic retinopathy is a leading cause of vision loss in adults with diabetes, and the role of systemic fibrate therapy in its prevention and progression remains debated. We performed a systematic review and meta-analysis to evaluate the effect of fibrates on diabetic retinopathy development and progression, distingui...

Luke M. Yaldo, Abdelaziz Abdelaal, Joshua Ong et al. · 0 citations
Review Sep 2026

Role of Lifestyle Modification in Preventing Diabetic Retinopathy

The vision-threatening stages of diabetic retinopathy (DR), which is still one of the main causes of vision loss, are mostly determined by progression rather than onset.  The need for scalable adjuncts like lifestyle modification is highlighted by the fact that, despite their effectiveness, pharmaceutical and procedura...

Muhammad Zahid Iqbal · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.